<DOC>
	<DOCNO>NCT02660320</DOCNO>
	<brief_summary>Principal objective : To compare efficacy laser-assisted dermabrasion + autologous epidermal cell suspension graft versus dermabrasion use micro-needling technique + autologous epidermal cell suspension graft dermabrasion use micro-needling technique + placebo suspension graft stable vitiligo . A total 10 patient stable non-segmental vitiligo include ITT population . In patient , three separate test area select part body . One area pre-treated dermaroller receive hyaluronic acid suspension alone two others receive epidermal cell suspension hyaluronic acid pre-treatment either dermaroller laser-assisted dermabrasion , patient control . Targeted phototherapy excimer lamp ( 308 nMm ) apply test area 1 week cell grafting .</brief_summary>
	<brief_title>Comparison Efficacy Micro-holes vs. Laser-assisted Dermabrasion , Repigmenting Vitiligo Skin</brief_title>
	<detailed_description>Condition Stable lesion Vitiligo adulthood Background Laser-assisted dermabrasion gold standard prepare graft bed epidermal suspension require technical platform train physician . Side effect uncommon . We demonstrate ex vivo study micro-needles create hole epidermis allow cell reach low layer epidermis . We hypothesize use micro-needles could effective easy technique prepare graft bed epidermal suspension . Objectives Principal objective : To compare efficacy laser-assisted dermabrasion + autologous epidermal cell suspension graft versus dermabrasion use micro-needling technique + autologous epidermal cell suspension graft dermabrasion use micro-needling technique + placebo suspension graft stable vitiligo . The secondary objective 1 . To evaluate compare tolerability distinct procedure 2 . To evaluate global satisfaction patient willingness reproduce procedure treat area 3 . To evaluate contrast treated skin perilesional area Methods Prospective , multicentre , randomize , control , blind assessor trial . Inclusion criterion - Men woman age 18 year old diagnosis non-segmental lesion stable three month - The minimum distance normal pigmented skin test area preferably least 0.5 cm . - For patient lesion locate area ( either chest , back , leg arm ) - The lesion area must : 2cm2 &lt; lesion &lt; 50cm2 - Treatment resistant area ( failure least one medical procedure topical tacrolimus topical steroid 6 month ) . - Absence infected lesion - Lesions stable least one year Exclusion criterion Hypersensibility local anaesthetic one component device ( trypsin , hyaluronic acid ) - Indication biopsy - Patient history melanoma - Positive serology ( ongoing serious systemic disease , herpes , HIV , hepatitis B C ) - History keloidal scar presence Koebner 's phenomenon ( type 1 type 2b ) - Infected lesion - Patient concomitant photosensitizing treatment - Age &lt; 18 year - Major deprive freedom administrative legal decision , subject legal protection measure , state express consent - Pregnant , deliver lactate patient . For woman childbearing potential , urinary pregnancy test do effective contraception expect . Interventions After inclusion visit , randomization occur visit 1 , day surgery determine lesion treat dermaroller+hyaluronic acid , dermaroller+VITICELL® laser-assisted dermabrasion+VITICELL® . Dermabrasion procedure : Three test area select part body . Each lesion respectively treat : - Dermaroller + hyaluronic acid + phototherapy - Dermaroller + VITICELL® + phototherapy - Laser + VITICELL® + phototherapy Dermabrasion use laser : To prepare graft recipient site , upper layer epidermis remove superficial dermabrasion use Erbium CO2 ablative laser . The test area ready receive suspension cell dermis appear . The cell suspension apply wound . Dermabrasion use dermaroller : The dermaroller apply treated area , dermabrasion technique base micro hole perform use 540 micro needle ( 200µm depth ) allow penetration suspension cell hyaluronic acid alone . Twelve passages perform treated area order achieve 60 % coverage . VITICELL® treat area : A small sample skin ( biopsy ) collect gluteal area . The biopsy measure 4 cm2 ( 2x2cm ) systematically . While investigator prepare area treat , skin place VITICELL® kit heath professional . The VITICELL® kit transform patient 's collect skin cellular suspension . The suspension epidermal cell apply ( 100µL per cm2 ) onto 2 selected lesions/areas dermabrasion dermaroller laser . Hyaluronic acid PBS treat area : The suspension hyaluronic acid apply ( 100 µL/cm2 ) onto select lesion dermabrasion dermaroller . Following surgery , treat area biopsy site cover dress must protect direct sun physical impact period 6 -7days . After period dress remove . Phototherapy : The phototherapy begin week cell graft use 2 time week treatment duration . The ultraviolet ( UV ) spectrum use test area . These different wavelength promote melanogenesis melanocyte proliferation graft side .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Hypopigmentation</mesh_term>
	<criteria>Men woman age 18 year old diagnosis nonsegmental lesion stable three month The minimum distance normal pigmented skin test area preferably least 0.5 cm . For patient lesion locate area ( either chest , back , leg arm ) The lesion area must : 2cm2 &lt; lesion &lt; 50cm2 Treatment resistant area ( failure least one medical procedure topical tacrolimus topical steroid 6 month ) . Absence infect lesion Lesions stable least one year Hypersensibility local anaesthetic one component device ( trypsin , hyaluronic acid ) Indication biopsies Patient history melanoma Positive serology ( ongoing serious systemic disease , herpes , HIV , hepatitis B C ) History keloidal scar presence Koebner 's phenomenon ( type 1 type 2b ) Infected lesion Patient concomitant photosensitize treatment Age &lt; 18 year Major deprive freedom administrative legal decision , subject legal protection measure , state express consent Pregnant , deliver lactate patient . For woman childbearing potential , urinary pregnancy test do effective contraception expect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>